Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system

BACKGROUND: Several biomarkers have been separately described to select patients for immunotherapy (IO), but few studies integrate these markers. Di Maio, EPSILoN and the plasma microRNA signature classifier (MSC), are three different clinico, biochemical and molecular markers able to independently...

Descripción completa

Detalles Bibliográficos
Autores principales: Prelaj, Arsela, Proto, Claudia, Lo Russo, Giuseppe, Signorelli, Diego, Ferrara, Roberto, Mensah, Mavis, Galli, Giulia, De Toma, Alessandro, Viscardi, Giuseppe, Brambilla, Marta, Lobefaro, Riccardo, Trevisan, Benedetta, Trovò, Francesco, Torri, Valter, Sozzi, Gabriella, Garassino, Marina Chiara, Boeri, Mattia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354114/
https://www.ncbi.nlm.nih.gov/pubmed/32676324
http://dx.doi.org/10.21037/tlcr-20-231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354114/
https://www.ncbi.nlm.nih.gov/pubmed/32676324
http://dx.doi.org/10.21037/tlcr-20-231

Ejemplares similares